Enliven Therapeutics to Present at Upcoming Investor Conferences
Enliven Therapeutics (NASDAQ: ELVN), a clinical-stage biopharmaceutical company specializing in small molecule therapeutics, has announced its participation in three major upcoming investor conferences in May and June 2025:
- TD Cowen's 6th Annual Oncology Innovation Summit on May 27, 2025, at 1:00 p.m. ET
- Jefferies Global Healthcare Conference on June 4, 2025, at 4:20 p.m. ET
- Goldman Sachs Annual Global Healthcare Conference on June 10, 2025, at 4:00 p.m. ET
All presentations will be in fireside chat format and will be webcast live through the company's investor relations website, with recordings available for 90 days after each event.
Enliven Therapeutics (NASDAQ: ELVN), una società biofarmaceutica in fase clinica specializzata in terapie a piccole molecole, ha annunciato la sua partecipazione a tre importanti conferenze per investitori previste per maggio e giugno 2025:
- 6° Summit Annuale sull'Innovazione in Oncologia di TD Cowen il 27 maggio 2025 alle 13:00 ET
- Conferenza Globale sulla Sanità di Jefferies il 4 giugno 2025 alle 16:20 ET
- Conferenza Globale Annuale sulla Sanità di Goldman Sachs il 10 giugno 2025 alle 16:00 ET
Tutte le presentazioni saranno in formato fireside chat e saranno trasmesse in diretta streaming attraverso il sito web delle relazioni con gli investitori della società, con registrazioni disponibili per 90 giorni dopo ogni evento.
Enliven Therapeutics (NASDAQ: ELVN), una empresa biofarmacéutica en etapa clínica especializada en terapias de pequeñas moléculas, ha anunciado su participación en tres importantes conferencias para inversores que se llevarán a cabo en mayo y junio de 2025:
- Sexta Cumbre Anual de Innovación en Oncología de TD Cowen el 27 de mayo de 2025 a la 1:00 p.m. ET
- Conferencia Global de Salud de Jefferies el 4 de junio de 2025 a las 4:20 p.m. ET
- Conferencia Global Anual de Salud de Goldman Sachs el 10 de junio de 2025 a las 4:00 p.m. ET
Todas las presentaciones serán en formato charla informal y se transmitirán en vivo a través del sitio web de relaciones con inversores de la compañía, con grabaciones disponibles durante 90 días después de cada evento.
Enliven Therapeutics (NASDAQ: ELVN)는 소분자 치료제에 특화된 임상 단계 바이오제약 회사로서, 2025년 5월과 6월에 개최되는 세 가지 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다:
- 2025년 5월 27일 오후 1시(동부시간) TD Cowen 제6회 연례 종양학 혁신 서밋
- 2025년 6월 4일 오후 4시 20분(동부시간) Jefferies 글로벌 헬스케어 컨퍼런스
- 2025년 6월 10일 오후 4시(동부시간) Goldman Sachs 연례 글로벌 헬스케어 컨퍼런스
모든 발표는 파이어사이드 채팅 형식으로 진행되며, 회사의 투자자 관계 웹사이트를 통해 실시간 중계되며 각 행사 후 90일 동안 녹화본을 시청할 수 있습니다.
Enliven Therapeutics (NASDAQ : ELVN), une société biopharmaceutique en phase clinique spécialisée dans les thérapeutiques à petites molécules, a annoncé sa participation à trois grandes conférences pour investisseurs prévues en mai et juin 2025 :
- 6e Sommet annuel sur l'innovation en oncologie de TD Cowen le 27 mai 2025 à 13h00 ET
- Conférence mondiale sur la santé de Jefferies le 4 juin 2025 à 16h20 ET
- Conférence mondiale annuelle sur la santé de Goldman Sachs le 10 juin 2025 à 16h00 ET
Toutes les présentations se dérouleront sous forme de discussion informelle et seront diffusées en direct sur le site des relations investisseurs de la société, avec des enregistrements disponibles pendant 90 jours après chaque événement.
Enliven Therapeutics (NASDAQ: ELVN), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Therapeutika mit kleinen Molekülen spezialisiert hat, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im Mai und Juni 2025 angekündigt:
- 6. jährlicher Oncology Innovation Summit von TD Cowen am 27. Mai 2025 um 13:00 Uhr ET
- Jefferies Global Healthcare Conference am 4. Juni 2025 um 16:20 Uhr ET
- Goldman Sachs Annual Global Healthcare Conference am 10. Juni 2025 um 16:00 Uhr ET
Alle Präsentationen werden im Fireside-Chat-Format gehalten und live über die Investor-Relations-Website des Unternehmens übertragen, wobei Aufzeichnungen 90 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
BOULDER, Colo., May 22, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will present at the following investor conferences:
TD Cowen's 6th Annual Oncology Innovation Summit: Insights from ASCO & EHA
Format: Fireside Chat
Date: Tuesday, May 27, 2025
Time: 1:00 p.m. ET
Jefferies Global Healthcare Conference
Format: Fireside Chat
Date: Wednesday, June 4, 2025
Time: 4:20 p.m. ET
Goldman Sachs Annual Global Healthcare Conference
Format: Fireside Chat
Date: Tuesday, June 10, 2025
Time: 4:00 p.m. ET
The fireside chats will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. Each webcast will be archived for a period of 90 days following the conclusion of the live event.
About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-upcoming-investor-conferences-302463238.html
SOURCE Enliven Therapeutics, Inc.
FAQ
When is Enliven Therapeutics (ELVN) presenting at the Goldman Sachs Healthcare Conference in 2025?
How can I watch Enliven Therapeutics' (ELVN) investor conference presentations in 2025?
What type of company is Enliven Therapeutics (ELVN)?
Which investor conferences is Enliven Therapeutics (ELVN) attending in May-June 2025?
